Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Ceribelli

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
The Journal of Biological Chemistry|August 20, 2009
NF-YC complexity is generated by dual promoters and alternative splicingMichele Ceribelli, Paolo Benatti, Carol Imbriano, et al.
Cell Cycle (Georgetown, Tex.)|May 25, 2006
Repression of new p53 targets revealed by ChIP on chip experimentsMichele Ceribelli, Myriam Alcalay, Maria Alessandra Viganò, et al.
Nature Immunology|September 22, 2011
Malignant pirates of the immune systemLixin Rui, Roland Schmitz, Michele Ceribelli, et al.
Pharmaceuticals (Basel, Switzerland)|December 23, 2023
Comparative Assessment and High-Throughput Drug-Combination Profiling of TEAD-Palmitoylation Inhibitors in Hippo Pathway Deficient MesotheliomaLale Evsen, Patrick J Morris, Craig J Thomas, et al.
Cold Spring Harbor Perspectives in Medicine|February 5, 2014
Oncogenic mechanisms in Burkitt lymphomaRoland Schmitz, Michele Ceribelli, Stefania Pittaluga, et al.
Plos One|May 1, 2008
An NF-Y-dependent switch of positive and negative histone methyl marks on CCAAT promotersGiacomo Donati, Raffaella Gatta, Diletta Dolfini, et al.
The Journal of Biological Chemistry|October 2, 2004
NF-Y regulates the antisense promoter, bidirectional silencing, and differential epigenetic marks of the Kcnq1 imprinting control regionRadha Raman Pandey, Michele Ceribelli, Prim B Singh, et al.
Molecular and Cellular Biology|January 24, 2008
The histone-like NF-Y is a bifunctional transcription factorMichele Ceribelli, Diletta Dolfini, Daniele Merico, et al.
Molecular Pharmacology|June 18, 2005
Selective effects of the anticancer drug Yondelis (ET-743) on cell-cycle promotersMario Minuzzo, Michele Ceribelli, Marià Pitarque-Martì, et al.
The Journal of Experimental Medicine|October 9, 2013
Transcription factor Runx2 controls the development and migration of plasmacytoid dendritic cellsCatherine M Sawai, Vanja Sisirak, Hiyaa S Ghosh, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
The Journal of Biological Chemistry|August 20, 2009
NF-YC complexity is generated by dual promoters and alternative splicingMichele Ceribelli, Paolo Benatti, Carol Imbriano, et al.
Cell Cycle (Georgetown, Tex.)|May 25, 2006
Repression of new p53 targets revealed by ChIP on chip experimentsMichele Ceribelli, Myriam Alcalay, Maria Alessandra Viganò, et al.
Nature Immunology|September 22, 2011
Malignant pirates of the immune systemLixin Rui, Roland Schmitz, Michele Ceribelli, et al.
Pharmaceuticals (Basel, Switzerland)|December 23, 2023
Comparative Assessment and High-Throughput Drug-Combination Profiling of TEAD-Palmitoylation Inhibitors in Hippo Pathway Deficient MesotheliomaLale Evsen, Patrick J Morris, Craig J Thomas, et al.
Cold Spring Harbor Perspectives in Medicine|February 5, 2014
Oncogenic mechanisms in Burkitt lymphomaRoland Schmitz, Michele Ceribelli, Stefania Pittaluga, et al.
Plos One|May 1, 2008
An NF-Y-dependent switch of positive and negative histone methyl marks on CCAAT promotersGiacomo Donati, Raffaella Gatta, Diletta Dolfini, et al.
The Journal of Biological Chemistry|October 2, 2004
NF-Y regulates the antisense promoter, bidirectional silencing, and differential epigenetic marks of the Kcnq1 imprinting control regionRadha Raman Pandey, Michele Ceribelli, Prim B Singh, et al.
Molecular and Cellular Biology|January 24, 2008
The histone-like NF-Y is a bifunctional transcription factorMichele Ceribelli, Diletta Dolfini, Daniele Merico, et al.
Molecular Pharmacology|June 18, 2005
Selective effects of the anticancer drug Yondelis (ET-743) on cell-cycle promotersMario Minuzzo, Michele Ceribelli, Marià Pitarque-Martì, et al.
The Journal of Experimental Medicine|October 9, 2013
Transcription factor Runx2 controls the development and migration of plasmacytoid dendritic cellsCatherine M Sawai, Vanja Sisirak, Hiyaa S Ghosh, et al.
Pageof 7